INVESTMENTS TO BOLSTER VACCINE MANUFACTURING CAPACITY

UK Government and Valneva confirm multi-million-pound up-front investment in Livingston manufacturing facility, following agreement to secure 60 million coronavirus vaccine doses. The Valneva’s site in Livingston will manufacture the vaccine, supporting the jobs of more than 100 highly-skilled scientists and technicians. The  Latest deal follows a number of agreements to procure millions of doses of vaccines, ensuring the greatest possible chance of securing access to a safe and effective vaccine.

Continue reading

A Third of Shielders do NOT want to go back to work

New figures published by the Office of National Statistics this morning reveal one in three “shielders” do not feel at all comfortable about working outside of their home.
The findings show: Approximately one-third (196,000, 32%) of CEV (clinically extremely vulnerable) people who normally work said they were not at all comfortable with working outside the home, compared with 24% (estimated 151,000) who were completely comfortable and 44% (estimated 276,000) who were comfortable if either they or their employer could put protective measures in place.